𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis

✍ Scribed by Staffan Törngren

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
270 KB
Volume
67
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of graduated compression stockin
The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis
✍ A. Allan; J. T. Williams; J. P. Bolton; Professor L. P. Le Quesne 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 2 views

## Abstract The efficacy of graduated compression stockings in the prevention of postoperative deep vein thrombosis was studied in a randomized, prospective, controlled trial of 200 patients, aged 40 years and over, undergoing abdominal surgery (100 for benign disease, 100 for malignant conditions)

The failure of compression stockings (tu
The failure of compression stockings (tubigrip) to prevent deep venous thrombosis after operation
✍ David S. Rosengarten; James Laird; K. Jeyasingh; Peter Martin 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 1 views

## Abstract With this method of investigation it appears that compression stockings have no value in preventing venous thrombosis after operation. Clinical diagnosis is unreliable in detecting the presence of deep-vein thrombosis. We have confirmed that the incidence of deepvein thrombosis after op

Heparin/dihydroergotamine for venous thr
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery
✍ Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. Møller-Larsen; V. E. Knud 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo